Cyclophosphamide modulates renal GSK-3β and NF-κB p65 expression in MRL/lpr mice with lupus nephritis
American Journal of Clinical and Experimental Immunology · 2026 · 15 (5) · 372-382
DOI: 10.62347/lyiw4654 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Clinical and Experimental Immunology, 2026. Verfasst von Liuna Liang und 6 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Liang, L., Yang, Z., Chen, Y., Gong, N., Li, L., Zhang, H., & Zhou, S. (2026). Cyclophosphamide modulates renal GSK-3β and NF-κB p65 expression in MRL/lpr mice with lupus nephritis. American Journal of Clinical and Experimental Immunology, 15(5), 372-382. https://doi.org/10.62347/lyiw4654
Vancouver
Liang L, Yang Z, Chen Y, Gong N, Li L, Zhang H, et al. Cyclophosphamide modulates renal GSK-3β and NF-κB p65 expression in MRL/lpr mice with lupus nephritis. American Journal of Clinical and Experimental Immunology. 2026;15(5):372-382. doi:10.62347/lyiw4654
BibTeX
@article{Liang2026,
author = {Liang, Liuna and Yang, Zhian and Chen, Ying and Gong, Ningning and Li, Linzhu and Zhang, Haoling and Zhou, Shuhong},
title = {Cyclophosphamide modulates renal GSK-3β and NF-κB p65 expression in MRL/lpr mice with lupus nephritis},
journal = {American Journal of Clinical and Experimental Immunology},
year = {2026},
volume = {15},
number = {5},
pages = {372--382},
doi = {10.62347/lyiw4654}
}
EUVIMED